In the comprehensive analysis of 70 HNSCC tumors at various stages of the disease, we found at least one significant TP53 genetic alteration in 79% of the tumor samples, which is consistent with previous studies that reported ~85% somatically mutated TP53 genes in smoking-related HNSCC [21,28]. Here, TP53 is linked to neoplasm.